Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

Cited by (910)

Items 401–500 of 910

  1. DUSP6 regulates drug sensitivity by modulating DNA damage response
    Tetyana Bagnyukova, Diana Restifo, Neil Beeharry, Linara Gabitova, Tai Li, Ilya G. Serebriiskii, Erica A. Golemis, Igor A. Astsaturov · 2013 · British Journal of Cancer
  2. DNA Damage–Induced Modulation of GLUT3 Expression Is Mediated through p53-Independent Extracellular Signal-Regulated Kinase Signaling in HeLa Cells
    Masaru Watanabe, Hiroaki Naraba, Tomoko Sakyo, Takayuki Kitagawa · 2010 · Molecular Cancer Research
  3. KRAS Mutation Dictates the Cancer Immune Environment in Pancreatic Ductal Adenocarcinoma and Other Adenocarcinomas
    Gu, Meichen, Gao, Yanli, Chang, Pengyu · 2021 · Cancers
  4. Molecular Pathways: Regulation of Metabolism by RB
    Brian F. Clem, Jason Alan Chesney · 2012 · Clinical Cancer Research
  5. GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase
    Roger J. Liang, Samuel R. Taylor, Navid Nahiyaan, Junho Song, Charles J. Murphy, Ezequiel Dantas, Shuyuan Cheng, Ting-Wei Hsu, Shakti Ramsamooj, Rahul Grover et al. · 2021 · Cancer & Metabolism
  6. Lack of association between KRAS mutations and 18F-FDG PET/CT in Caucasian metastatic colorectal cancer patients.
    Dimitrios Krikelis, Evangelia V. Skoura, Vassiliki Kotoula, Phivi Rondogianni, Nikoletta K. Pianou, Alexandros P. Samartzis, Ioannis Xanthakis, George Fountzilas, Ioannis Datseris · 2014 · PubMed
  7. GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ
    Zongwei Li, Yingying Wang, Ian P. Newton, Lichao Zhang, Pengyu Ji, Zhuoyu Li · 2015 · Cellular Signalling
  8. 18F-FAZA PET Imaging Response Tracks the Reoxygenation of Tumors in Mice upon Treatment with the Mitochondrial Complex I Inhibitor BAY 87-2243
    Edwin Chang, Hongguang Liu, Kerstin Unterschemmann, Peter Ellinghaus, Shuanglong Liu, Volker Gekeler, Zhen Cheng, Dietmar Berndorff, Sanjiv Sam Gambhir · 2014 · Clinical Cancer Research
  9. Targeting Glucose Transporter 1 (GLUT1) in Cancer: Molecular Mechanisms and Nanomedicine Applications
    Zhen Ren, Jingyuan Zhao, Shuai Li, Hong Yuan · 2025 · International Journal of Nanomedicine
  10. KRAS and BRAF Mutation Analysis in Colorectal Adenocarcinoma Specimens with a Low Percentage of Tumor Cells
    Marzena Anna Lewandowska, Wojciech Jóźwicki, Bogdan A. Żurawski · 2013 · Molecular Diagnosis & Therapy
  11. Determination of glucose in human stomach cancer cell extracts and single cells by capillary electrophoresis with a micro-biosensor
    Xiaolei Wang, Yanfang Ma, Man Zhao, Minfeng Zhou, Yan Xiao, Zifei Sun, Lili Tong · 2016 · Journal of Chromatography A
  12. KY1022, a small molecule destabilizing Ras via targeting the Wnt/β-catenin pathway, inhibits development of metastatic colorectal cancer
    Yong‐Hee Cho, Pu-Hyeon Cha, Saluja Kaduwal, Jong-Chan Park, Sang Gyu Lee, Jeong-Soo Yoon, Wookjin Shin, Hyuntae Kim, Eun Ji Ro, Kyung-Hwa Koo et al. · 2016 · Oncotarget
  13. Reconciling environment-mediated metabolic heterogeneity with the oncogene-driven cancer paradigm in precision oncology
    Catherine Vander Linden, Cyril Corbet · 2019 · Seminars in Cell and Developmental Biology
  14. Plasma miRNA Biomarkers in Limited Volume Samples for Detection of Early-stage Pancreatic Cancer
    Rachel L. Dittmar, Suyu Liu, Mei-Chee Tai, Kimal Rajapakshe, Ying Huang, Gary Longton, Christine DeCapite, Mark W. Hurd, Pamela L. Paris, Kimberly Saunders Kirkwood et al. · 2021 · Cancer Prevention Research
  15. The hexosamine biosynthesis pathway and O‐Glc NA cylation maintain insulin‐stimulated PI 3K‐ PKB phosphorylation and tumour cell growth after short‐term glucose deprivation
    David R. Jones, Willem‐Jan Keune, Karen E. Anderson, Len Stephens, Phillip T. Hawkins, Nullin Divecha · 2014 · FEBS Journal
  16. Glucose-dependent glucose transporter 1 expression and its impact on viability of thyroid cancer cells
    Paweł Jóźwiak, Anna Krześlak, Magdalena Bryś, Anna Lipińska · 2014 · Oncology Reports
  17. Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma
    Lorey K. Smith, Aparna Dodla Rao, Grant A. McArthur · 2016 · Pharmacological Research
  18. Isoform-specific Ras signaling is growth factor dependent
    Fiona E. Hood, Bertram Klinger, Anna U. Newlaczyl, Anja Sieber, Mathurin Dorel, Simon P. Oliver, Judy M. Coulson, Nils Blüthgen, Ian A. Prior · 2019 · Molecular Biology of the Cell
  19. Restoring PUMA induction overcomes KRAS-mediated resistance to anti-EGFR antibodies in colorectal cancer
    Knickelbein, Kyle, Tong, Jingshan, Chen, Dongshi, Wang, Yi-Jun, Misale, Sandra, Bardelli, Alberto, Yu, Jian, Zhang, Lin · 2018 · Oncogene
  20. microRNA-193a-3p is specifically down-regulated and acts as a tumor suppressor in BRAF-mutated colorectal cancer
    Hidekazu Takahashi, Masanobu Takahashi, Shinobu Ohnuma, Michiaki Unno, Yuki Yoshino, Kota Ouchi, Shinʼ ichi Takahashi, Yasuhide Yamada, Hideki Shimodaira, Chikashi Ishioka · 2017 · BMC Cancer
  21. The induction of HAD-like phosphatases by multiple signaling pathways confers resistance to the metabolic inhibitor 2-deoxyglucose
    Quentin Defenouillère, Agathe Verraes, Clotilde Laussel, Anne Friedrich, Joseph Schacherer, Sébastien Léon A · 2019 · Science Signaling
  22. A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma
    Hua Yang, Mu-Zi-he Zhang, Huiwei Sun, Yantao Chai, Xiaojuan Li, Qiyu Jiang, Jun Hou · 2021 · Frontiers in Oncology
  23. Cancer biology in diabetes
    Sen Shi, Yanzheng He, Daisuke Koya, Keizo Kanasaki · 2014 · Journal of Diabetes Investigation
  24. Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
    Debarshi Roy, Susmita Mondal, Chen Wang, Xiaoping He, Ashwani Khurana, Shailendra Giri, Robert G. Hoffmann, Deok‐Beom Jung, Sung H Kim, Eduardo N. Chini et al. · 2014 · Cancer & Metabolism
  25. Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells
    Marijke C.C. Sachweh, William C. Stafford, Catherine J. Drummond, Anna R. McCarthy, Maureen Higgins, Johanna Campbell, Bertha A. Brodin, Elias S.J. Arnér, Sonia Laı́n · 2015 · Oncotarget
  26. Determination of glucose deficiency-induced cell death by mitochondrial ATP generation-driven proton homeostasis
    Yanfen Cui, Yuanyuan Wang, Miao Liu, Li Qiu, Pan Xing, Xin Wang, Guoguang Ying, Binghui Li · 2017 · Journal of Molecular Cell Biology
  27. Glycemic Variability Promotes Both Local Invasion and Metastatic Colonization by Pancreatic Ductal Adenocarcinoma
    Ziying Jian, Tao Cheng, Zhiheng Zhang, Susanne Raulefs, Kuangyu Shi, Katja Steiger, Nadja Maeritz, Karin Kleigrewe, Thomas Hofmann, Simone Benitz et al. · 2018 · Cellular and Molecular Gastroenterology and Hepatology
  28. Dysregulation of the miR-148a–GLUT1 axis promotes the progression and chemoresistance of human intrahepatic cholangiocarcinoma
    Pei Tiemin, Peng Xiao, lang Qingfu, Yan Wang, Xue Junlin, He Zhefeng, Zhao Ming, Liang Desen, Meng Qinghui · 2020 · Oncogenesis
  29. Specific activation of glycolytic enzyme enolase 2 in BRAF V600E‐mutated colorectal cancer
    Ryohei Yukimoto, Naohiro Nishida, Tsuyoshi Hata, Shiki Fujino, Takayuki Ogino, Norikatsu Miyoshi, Hidekazu Takahashi, Mamoru Uemura, Taroh Satoh, Hirofumi Yamamoto et al. · 2021 · Cancer Science
  30. Facile synthesis of multifunctional pharmaceutical carbon dots for targeted bioimaging and chemotherapy of tumors
    Jiafeng Wan, Shiqing Xu, Jing Li, Mengliu Yu, Kai Zhang, Gang Wei, Zhiqiang Su · 2022 · Nanoscale
  31. Diverse antitumor effects of ascorbic acid on cancer cells and the tumor microenvironment
    Takeru Maekawa, Toru Miyake, Masaji Tani, Shinji Üemoto · 2022 · Frontiers in Oncology
  32. Deregulated Metabolic Pathways in Ovarian Cancer: Cause and Consequence
    Roopak Murali, Vaishnavi Balasubramaniam, Satish Srinivas, Sandhya Sundaram, Ganesh Venkatraman, Sudha R. Warrier, Arun Dharmarajan, Rajesh Kumar Gandhirajan · 2023 · Metabolites
  33. Tumor bioenergetics: An emerging avenue for cancer metabolism targeted therapy
    Hyun Jung Kee, Jae‐Ho Cheong · 2014 · BMB Reports
  34. A Case Report - Volatile Metabolomic Signature of Malignant Melanoma using Matching Skin as a Control
    Tatjana Abaffy, Mecker Geraldine Moller, Daniel D. Riemer, Clara Milikowski · 2011 · Journal of Cancer Science & Therapy
  35. Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics
    Philippe Marchetti, Pierre Guerreschi, Laurent Mortier, Jérôme Kluza · 2015 · International Journal of Cell Biology
  36. The metabolism-immune axis in colorectal cancer: remodeling the tumor microenvironment through metabolite signaling
    Shaofan Hu, Hui Heng, Fang Yang, Meng Wang, Guoxiang Liu, Yuancai Xiang, Hongming Miao · 2025 · Frontiers in Immunology
  37. Glutamine, Glucose and other Fuels for Cancer
    María Victoria Ruiz-Pérez, Francisca Sánchez‐Jiménez, Francisco José Alonso, Juan Segura, Javier Márquez, Miguel Ángel Medina · 2014 · Current Pharmaceutical Design
  38. Strategy to targeting the immune resistance and novel therapy in colorectal cancer
    Gang Wang, Junjie Wang, Rui Guan, Yan Sun, Feng Shi, Jiayan Zhang, Zimeng Li, Jing Gao, Xingli Fu · 2018 · Cancer Medicine
  39. Inhibitory ASIC2-mediated calcineurin/NFAT against colorectal cancer by triterpenoids extracted from Rhus chinensis Mill
    Gang Wang, Yu-Zhu Wang, Yang Yu, Junjie Wang · 2019 · Journal of Ethnopharmacology
  40. Moonlighting Metabolic Enzymes in Cancer: New Perspectives on the Redox Code
    Jingwen Jiang, Liyuan Peng, Kui Wang, Canhua Huang · 2020 · Antioxidants and Redox Signaling
  41. Another Consequence of the Warburg Effect? Metabolic Regulation of Na+/H+ Exchangers May Link Aerobic Glycolysis to Cell Growth
    Eivind Salmorin Birkeland, Lisa Maria Koch, Reinhard Christoph Dechant · 2020 · Frontiers in Oncology
  42. Restricting Glutamine Uptake Enhances NSCLC Sensitivity to Third-Generation EGFR-TKI Almonertinib
    Yaming Liu, Xianming Ge, Jinlong Pang, Yuhan Zhang, Hao Zhang, Hongyan Wu, Fangtian Fan, Hao Liu · 2021 · Frontiers in Pharmacology
  43. The Ubiquitin–Proteasome System in Tumor Metabolism
    Jie Wang, Yuandi Xiang, Mengqi Fan, Shizhen Fang, Qingquan Hua · 2023 · Cancers
  44. Ca 2+ -dependent demethylation of phosphatase PP2Ac promotes glucose deprivation–induced cell death independently of inhibiting glycolysis
    Ha Yin Lee, Yoko Itahana, Stefan Schüchner, Masahiro Fukuda, Hyunsoo Shawn Je, Egon Ogris, David M. Virshup, Koji Itahana · 2018 · Science Signaling
  45. Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells
    Lara Macchioni, Magdalena Davidescu, Miriam Sciaccaluga, Cristina Marchetti, Graziella Migliorati, Stefano Coaccioli, Rita Roberti, Lanfranco Corazzi, Emilia Castigli · 2011 · Journal of Bioenergetics and Biomembranes
  46. Cancer cell metabolism, epigenetics and the potenti al influence of dietary components - A perspective.
    Clarissa Gerhäuser · 2012
  47. Adrenomedullin is a therapeutic target in colorectal cancer
    Liangjing Wang, Manish K. Gala, Masayoshi Yamamoto, Maria Simona Pino, Hirotoshi Kikuchi, Daniel S. Shue, Senji Shirasawa, Thomas R. Austin, Maureen P. Lynch, Bo R. Rueda et al. · 2013 · International Journal of Cancer
  48. A β-Camera Integrated with a Microfluidic Chip for Radioassays Based on Real-Time Imaging of Glycolysis in Small Cell Populations
    Nam T. Vu, Zeta Tak For Yu, Begonya Comin-Anduix, Jonas Nørskov Søndergaard, Robert W. Silverman, Canny Y. N. Chang, Antoni Ribas, Hsian‐Rong Tseng, Arion F. Chatziioannou · 2011 · Journal of Nuclear Medicine
  49. KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer
    Hiroaki Niitsu, Takao Hinoi, Y Kawaguchi, Kazuhiro Sentani, Ryo Yuge, Yasuhiko Kitadai, Yusuke Sotomaru, T Adachi, Yasufumi Saito, Masashi Miguchi et al. · 2016 · Oncogenesis
  50. Caring for cells in microsystems: principles and practices of cell-safe device design and operation
    Sarvesh Varma, Joel Voldman B · 2018 · Lab on a Chip
  51. GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer
    Kai Zeng, Gaoda Ju, Hao Wang, Jiang-Sheng Huang · 2020 · Translational Cancer Research
  52. Metabolic plasticity allows cancer cells to thrive under nutrient starvation
    Wilhelm Palm · 2021 · Proceedings of the National Academy of Sciences
  53. Metabolic adaptations determine whether natural killer cells fail or thrive within the tumor microenvironment
    Adnan Moinuddin, Sophie M. Poznanski, Ana L. Portillo, Jonathan K. Monteiro, Ali A. Ashkar · 2024 · Immunological Reviews
  54. Emerging Trends in Gastrointestinal Cancer Targeted Therapies: Harnessing Tumor Microenvironment, Immune Factors, and Metabolomics Insights
    Sanchita Rauth, Mokenge Peter Malafa, Moorthy Palanimuthu Ponnusamy, Surinder K. Batra · 2024 · Gastroenterology
  55. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells
    Koichi Okamoto, Aziz Zaanan, Hisato Kawakami, Shengbing Huang, Frank A. Sinicrope · 2014 · Molecular Cancer Research
  56. The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
    Magdalena Davidescu, Lara Macchioni, Gaetano Scaramozzino, Maria Cristina Marchetti, Graziella Migliorati, Rita Vitale, Angela Corcelli, Rita Roberti, Emilia Castigli, Lanfranco Corazzi · 2015 · Scientific Reports
  57. Does nutrition for cancer patients feed the tumour? A clinical perspective
    Federico Bozzetti, Zeno Giovanni Stanga · 2020 · Critical Reviews in Oncology/Hematology
  58. Common and mutation specific phenotypes of KRAS and BRAF mutations in colorectal cancer cells revealed by integrative -omics analysis
    Snehangshu Kundu, Muhammad Akhtar Ali, Niklas Handin, Louis Patrick Conway, Verónica Rendo, Per Artursson, Liqun He, Daniel Globisch, Tobias Sjöblom · 2021 · Journal of Experimental & Clinical Cancer Research
  59. The BRAF V600E Mutation in Papillary Thyroid Carcinoma Is Associated with Glucose Transporter 1 Overexpression
    Florian Grabellus, Karl Worm, Kurt Werner Schmid, Sien‐Yi Sheu · 2011 · Thyroid
  60. Fetal Bovine Serum
    Mary Johnson · 2012 · Materials and Methods
  61. miR-27a promotes proliferation, migration, and invasion of colorectal cancer by targeting FAM172A and acts as a diagnostic and prognostic biomarker
    Wenjun Liu, Kai Qian, Xing Wei, Haijun Deng, Bei Zhao, Qing Chen, Jinqian Zhang, Hao Liu · 2017 · Oncology Reports
  62. The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
    Je Lin Sieow, Sin Yee Gun, Siew Cheng Wong · 2018 · Frontiers in Cell and Developmental Biology
  63. Metabolic implication of tumor:stroma crosstalk in breast cancer
    Andrea Morandi, Paola Chiarugi · 2014 · Journal of Molecular Medicine
  64. Glutamate dehydrogenase 1 mediated glutaminolysis sustains HCC cells survival under glucose deprivation
    Yu-Jiao Zhou, Haibo Yu, Sheng‐Tao Cheng, Yao Chen, Lin He, Ji‐Hua Ren, Xin Qi He, Juan Chen, Lu Zheng, Fan Li et al. · 2022 · Journal of Cancer
  65. 18[F]FDG-PET/CT is a Useful Molecular Marker in Evaluating Tumour Aggressiveness: A Revised Understanding of an In-Vivo FDG-PET Imaging that Alludes the Alteration of Cancer Biology
    F. Fathinul, Abdul Jalil Nordin, Eddie W. F. Lau · 2012 · Cell Biochemistry and Biophysics
  66. Prognostic biomarkers in colorectal cancer: where do we stand?
    Xavier Sagaert · 2014 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  67. PPARα Promotes Cancer Cell Glut1 Transcription Repression
    Mengli You, Jianhua Jin, Qian Liu, Qinggang Xu, Juanjuan Shi, Yongzhong Hou · 2016 · Journal of Cellular Biochemistry
  68. A small molecule approach to degrade RAS with EGFR repression is a potential therapy for KRAS mutation-driven colorectal cancer resistance to cetuximab
    Sang Gyu Lee, Yong‐Hee Cho, Pu-Hyeon Cha, Jeong-Soo Yoon, Eun Ji Ro, Woo-Jeong Jeong, Jieun Park, Hyuntae Kim, Tae Il Kim, Do Sik Min et al. · 2018 · Experimental & Molecular Medicine
  69. Knockout of Dual-Specificity Protein Phosphatase 5 Protects Against Hypertension-Induced Renal Injury
    Chao Zhang, Xiaochen He, Sydney Murphy, Huawei Zhang, Shaoxun Wang, Ying Chun Ge, Wen‐Jun Gao, Jan Michael Williams, Aron M. Geurts, Richard J. Roman et al. · 2019 · Journal of Pharmacology and Experimental Therapeutics
  70. AMPK activation overcomes anti-EGFR antibody resistance induced by KRAS mutation in colorectal cancer
    Ye, Hua, Liu, Yi, Wu, Kefeng, Luo, Hui, Cui, Liao · 2020 · Cell Communication and Signaling
  71. GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells
    Masato Hayashi, Keishi Nakamura, Shinichi Harada, Mariko Hori Tanaka, Akiko Kobayashi, Hiroto Saito, Toshikatsu Tsuji, Daisuke Yamamoto, Hideki Moriyama, Jun Kinoshita et al. · 2025 · BMC Cancer
  72. Elucidating tumor-stromal metabolic crosstalk in colorectal cancer through integration of constraint-based models and LC-MS metabolomics
    Junmin Wang, Alireza Delfarah, Patrick E. Gelbach, Emma J. Fong, Paul Macklin, Shannon M. Mumenthaler, Nicholas Alexander Graham, Stacey D. Finley · 2021 · Metabolic Engineering
  73. Noninvasive and Highly Selective Monitoring of Intracellular Glucose via a Two-Step Recognition-Based Nanokit
    Jianru Tang, Dandan Ma, Stevan Pecic, Caixia Huang, Jing Zheng, Jishan Li, Ronghua Yang · 2017 · Analytical Chemistry
  74. Metabolic rewiring drives resistance to targeted cancer therapy
    Jason W. Locasale · 2012 · Molecular Systems Biology
  75. Metabolic Biomarker–Based BRAFV600 Mutation Association and Prediction in Melanoma
    Hanna Saadani, Bernies van der Hiel, Else A. Aalbersberg, Ioannis Zavrakidis, John B.A.G. Haanen, Otto S. Hoekstra, Ronald Boellaard, Marcel P. M. Stokkel · 2019 · Journal of Nuclear Medicine
  76. Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer
    Suhu Liu, Helen I. Gandler, Isidora Tošić, Darwin Q. Ye, Zachary T. Giaccone, David A. Frank · 2021 · Molecular Cancer Research
  77. Molecular Biology and Therapeutic Perspectives for K-Ras Mutant Non-Small Cell Lung Cancers
    Elona Cekani, Samantha Epistolio, Giulia Dazio, Marco Cefalì, Luciano Wannesson, Milo Frattini, Patrizia Froesch · 2022 · Cancers
  78. The utility of diagnostic biopsy specimens for predictive molecular testing in colorectal cancer
    Wakkas Fadhil, Salih Ibrahem, Rashmi Seth, Ghada AbuAli, Krishna Ragunath, Philip Kaye, Mohammad Ilyas · 2012 · Histopathology
  79. Bioactive Food Components and Cancer‐Specific Metabonomic Profiles
    Young Shin Kim, John A. Milner · 2010 · BioMed Research International
  80. Annual fasting plasma glucose variation increases risk of cancer incidence and mortality in patients with type 2 diabetes: the Taichung Diabetes Study
    Cheng‐Chieh Lin, Chia-Ing Li, Chiu-Shong Liu, Wen‐Yuan Lin, Ching‐Chu Chen, Sing-Yu Yang, Cheng-Chun Lee, Tsai‐Chung Li · 2012 · Endocrine Related Cancer
  81. A new facet of NDRG1 in pancreatic ductal adenocarcinoma: Suppression of glycolytic metabolism
    Wensheng Liu, Bo Zhang, Qiangsheng Hu, Yi Qin, Wenyan Xu, Si Shi, Chen Liang, Qingcai Meng, Jinfeng Xiang, Dingkong Liang et al. · 2017 · International Journal of Oncology
  82. Energy stress-induced circZFR enhances oxidative phosphorylation in lung adenocarcinoma via regulating alternative splicing
    Zhifei Ma, Hao Chen, Zhijun Xia, Jing You, Chencheng Han, Siwei Wang, Wenjia Xia, Yongkang Bai, Tongyan Liu, Lin Xu et al. · 2023 · Journal of Experimental & Clinical Cancer Research
  83. Autophagy sustains mitochondrial respiration and determines resistance to BRAF V600E inhibition in thyroid carcinoma cells
    Sergio Díaz Gago, Javier Vicente-Gutiérrez, Jose Manuel Ruiz-Rodríguez, Josep Calafell-Segura, Alicia Álvarez-Álvarez, Marina Lasa, Antonio Chiloeches, Pablo Baquero · 2024 · Autophagy
  84. DR4-Ser424O-GlcNAcylation Promotes Sensitization of TRAIL-Tolerant Persisters and TRAIL-Resistant Cancer Cells to Death
    Hyeon-Jeong Lee, Yumin Oh, Young-Jun Jeon, Song-Yi Lee, Hyun‐Joo Kim, Ho-June Lee, Yong‐Keun Jung · 2019 · Cancer Research
  85. Metabolic switch in cancer – Survival of the fittest
    Hans Raskov, Shruti Gaggar, Asma Tajik, Adile Orhan, Ismail Gögenür · 2022 · European Journal of Cancer
  86. Cancer plasticity: Investigating the causes for this agility
    Shubhraneel Saha, Nikita Pradhan, B Neha, Ravikiran Mahadevappa, Shilpi Minocha, Saran Kumar · 2022 · Seminars in Cancer Biology
  87. Energy metabolism and proliferation in pancreatic carcinogenesis
    I. Regel, B. Kong, S. Raulefs, M. Erkan, C. Michalski, M. Hartel, J. Kleeff · 2012 · Langenbeck's archives of surgery (Print)
  88. Metabolic effects of antiangiogenic drugs in tumors: Therapeutic implications
    Luigi Quintieri, Mohamed Selmy, Stefano Indraccolo · 2014 · Biochemical Pharmacology
  89. Maltotriose Conjugation to a Chlorin Derivative Enhances the Antitumor Effects of Photodynamic Therapy in Peritoneal Dissemination of Pancreatic Cancer
    Akihisa Kato, Hiromi Kataoka, Shigenobu Yano, Kazuki Hayashi, Noriyuki Hayashi, Mamoru Tanaka, Itaru Naitoh, Tesshin Ban, Katsuyuki Miyabe, Hiromu Kondo et al. · 2017 · Molecular Cancer Therapeutics
  90. Genome-wide Analysis Reveals DNA Methylation Alterations in Obesity Associated with High Risk of Colorectal Cancer
    Lixin Dong, Li Ma, Gloria H. Ma, Hongmei Ren · 2019 · Scientific Reports
  91. Perspective: Do Fasting, Caloric Restriction, and Diets Increase Sensitivity to Radiotherapy? A Literature Review
    Philippe Icard, Luc Ollivier, Patricia Forgez, Joëlle Otz, Marco Alifano, Ludovic Fournel, Mauro Loi, Juliette Thariat · 2020 · Advances in Nutrition
  92. AMPKα loss promotes KRAS-mediated lung tumorigenesis
    Manuela La Montagna, Lei Shi, Peter Magee, Sudhakar Sahoo, Matteo Fassan, Michela Garofalo · 2021 · Cell Death and Differentiation
  93. Mitochondrial Respiration in KRAS and BRAF Mutated Colorectal Tumors and Polyps
    Egle Rebane-Klemm, Laura Truu, Leenu Reinsalu, Marju Puurand, Igor N. Shevchuk, Vladimir A. Chekulayev, Natalja Timohhina, Kersti Tepp, Jelena Bogovskaja, Vladimir Afanasjev et al. · 2020 · Cancers
  94. BRAF activation by metabolic stress promotes glycolysis sensitizing NRASQ61-mutated melanomas to targeted therapy
    Kimberley McGrail, Paula Granado‐Martínez, Rosaura Esteve‐Puig, Sara García-Ortega, Yuxin Ding, Sara Sánchez‐Redondo, Berta Ferrer Fábrega, Javier Hernández‐Losa, Françesc Canals, Ànna Manzano et al. · 2022 · Nature Communications
  95. The α-Arrestin Bul1p Mediates Lactate Transporter Endocytosis in Response to Alkalinization and Distinct Physiological Signals
    Gabriel Talaia, Christos Gournas, Elie Saliba, Cláudia Barata-Antunes, Margarida Casal, Bruno André, George Diallinas, Sandra Paiva · 2017 · Journal of Molecular Biology
  96. The importance of BRAF‐V600E mutation to ameloblastoma metabolism
    Filipe Fideles Duarte‐Andrade, André Myller Barbosa Silva, Jéssica Gardone Vitório, Gisele André Baptista Canuto, Sara Ferreira dos Santos Costa, Marina Gonçalves Diniz, Ana Paula Fernandes, Juliano Simões de Toledo, Leiliane Coelho André, Carolina Cavaliéri Gomes et al. · 2019 · Journal of Oral Pathology and Medicine
  97. Metformin inhibits PPARδ agonist-mediated tumor growth by reducing Glut1 and SLC1A5 expressions of cancer cells
    Jiajun Ding, Qian Gou, Jianhua Jin, Juanjuan Shi, Qian Liu, Yongzhong Hou · 2019 · European Journal of Pharmacology
  98. Dual Inhibition of GLUT1 and the ATR/CHK1 Kinase Axis Displays Synergistic Cytotoxicity in KRAS -Mutant Cancer Cells
    Johanna Erber, Joachim David Steiner, Jörg Isensee, Leonard A. Lobbes, André Toschka, Filippo Beleggia, Anna Schmitt, Rainer W. J. Kaiser, Florian Siedek, Thorsten Persigehl et al. · 2019 · Cancer Research
  99. Vacuolar H+-ATPase Subunit V0C Regulates Aerobic Glycolysis of Esophageal Cancer Cells via PKM2 Signaling
    Sung Wook Son, Gia Cac Chau, Seong‐Tae Kim, Sung Hee Um · 2019 · Cells
  100. Global metabolic alterations in colorectal cancer cells during irinotecan-induced DNA replication stress
    Christian Marx, Jürgen Sonnemann, Oliver D.K. Maddocks, Lisa Marx-Blümel, Mandy Beyer, Doerte Hoelzer, René Thierbach, Claudia Maletzki, Michael Linnebacher, Thorsten Heinzel et al. · 2022 · Cancer & Metabolism